Press Releases

14 Oct 2024

CUHK Medical Centre, FWD Hong Kong, and Pfizer Hong Kong partner to raise migraine awareness　　　　　　　　　　　　　　　　　　　　　　　　Building a health information platform to help the public cope with migraine and provide free online assessments and professional follow-up

Migraine is a common type of moderate to severe headache, with more severe pains having an adverse impact on people’s daily lives¹. Research² has shown that around 12.5% of Hong Kong’s population suffers from migraine, especially among people aged 18 to 44³. Furthermore, women are three to four times more likely to suffer from migraine than men⁴. In response, CUHK Medical Centre (“CUHKMC”), FWD Hong Kong (“FWD”), and Pfizer Hong Kong collaborate to raise awareness and help the public to cope with migraine. FWD MAX lifestyle experience platform (fwdmax.fwd.com.hk) will publish a series of information on migraine and provide a free online migraine assessment. The first 50 users who meet the relevant health conditions can also receive a free migraine assessment service provided by the Clinical Neuroscience Centre of CUHKMC⁵, encouraging users to seek professional assistance and follow-up at the earliest opportunity. FWD MAX launches free online assessment to identify migraine risks early Many patients lack a full understanding of migraine, and incorrectly dismiss it as common headache to be cured by taking painkillers by themselves. This not only fails to address the real underlying issue, but risks making it worse through overuse of painkillers. To help the public identify and strengthen their understanding of migraine earlier, FWD MAX will continue to provide relevant health information and offer a free online migraine assessment. Users will be able to gain insights into their migraine health by answering five simple questions. Ken LAU, Managing Director of Greater China and Hong Kong Chief Executive Officer, FWD, said: “Urban dwellers live busy lifestyles and easily fall into the habit of neglecting their health. As an insurance company, FWD fully understands the importance of early diagnosis and treatment when it comes to effective health management. We provide comprehensive medical protection products and services, and actively collaborate with various medical institutions, covering services from prevention and treatment to rehabilitation stages. Our collaboration with CUHKMC and Pfizer Hong Kong specifically aims to enhance public awareness of migraine, hoping to encourage users in need to actively seek professional assistance, address their migraine troubles, and live a healthy life.” Don’t ignore migraine: early treatment brings relief, information platform empowers prevention Migraine is a common neurological disease. Patients experience severe headaches, usually coupled with nausea or vomiting, and it can last up to 72 hours at its worst, preventing patients from working or living normally. The causes of migraine, however, are complicated. Family history, hormonal changes in women, lack of sleep, stress, anxiety, smoking, and even weather changes can all trigger migraine. Early treatment is especially important for controlling migraine because it alleviates symptoms more effectively, while also reducing both the frequency and severity of attacks. CUHKMC and Pfizer Hong Kong will regularly share professional information on FWD MAX to help patients understand the causes, symptoms, and treatments of migraine, empowering them to master the way of preventive care. Dr Hong FUNG, Chief Executive Officer of CUHK Medical Centre, said, “CUHKMC is committed to promoting public health education and enhancing public awareness towards diseases, as well as the importance of prevention and early treatment, which can ultimately improve the population health in the long run. This time, we are pleased to collaborate with FWD Hong Kong and Pfizer Hong Kong, enabling more people to pay attention to migraine issues. This initiative helps those with migraine risks to be aware of their own conditions earlier and receive appropriate treatment advice through the programme, preventing the problem from worsening due to delayed treatment.” Three institutions join hands to promote and raise public awareness of migraine, one of the world’s most common diseases “We are excited to join forces with CUHKMC and FWD Hong Kong in the fight against migraine and help those patients impacted by this debilitating neurological disease,” said Krishnamoorthy SUNDARESAN, General Manager, Pfizer Hong Kong and Macau. “We believe this partnership will significantly increase public awareness on the disease and the subsequent burden, in order to co-create a more supportive environment for patients living with migraine pain.” Free online assessment for the first 50 users who meet the relevant health conditions to receive a free migraine assessment service Visit https://fwdmax.fwd.com.hk/en/Events/migraine2024 or download the FWD MAX app to learn about migraine and take the online migraine assessment. All users who complete the online assessment will receive a convenience store e-cash coupon worth HKD20. The first 50 users who meet relevant health conditions can also receive a free migraine assessment service (valued at HKD500)⁵ provided by the Clinical Neuroscience Centre of CUHKMC, encouraging users to seek early professional assistance and follow-up.   ¹ NHS. Migraine: Overview. Available at: www.nhs.uk/conditions/migraine/. Accessed Feb 2023; Peters GL. Am J Manag Care 2019;25:S23-S34; Pescador Ruschel MA, De Jesus O. Migraine Headaches. Available at: www.ncbi.nlm.nih.gov/books/NBK560787/. Accessed Feb 2023; Mayo Clinic. Migraine: Symptoms & causes. Available at: www.mayoclinic.org/diseases-conditions/migraine-headache/symptoms-causes/syc-20360201. Accessed Feb 2023; National Institute of Neurological Disorders and Stroke. Headache. Available at: www.ninds.nih.gov/health-information/disorders/headache. Accessed Feb 2023;  ² Cheung, Raymond TF. Headache: The Journal of Head and Face Pain 40.6 (2000): 473-479. ³ Peters GL. Am J Manag Care 2019;25:S23-S34.   ⁴ Al-Hassany L, Haas J, et al. Frontiers in Neurology. 2020;11:549038. ⁵ Terms and conditions apply, available while stocks last. FWD Life, in its sole discretion, determines the qualification for receiving the prize. The e-coupon will be credited into users' registered FWD MAX account's "Just for you" wallet within 30 days. Migraine assessment service is provided by the CUHK Medical Centre. The first 50 eligible participants will receive a redemption letter 10 working days after completing the questionnaire. The redemption letter will be sent by FWD MAX to the users’ registered FWD MAX email address. Please refer to the redemption letter for the redemption and booking details.  

16 Sep 2024

中大醫院加盟成為友邦香港客戶網絡醫院 讓病人於中大醫院享有預先批核及出院免找數服務 助清晰掌握醫療費用預算 安心專注治療 (Only available in Chinese)

Only available in Chinese

02 Aug 2024

CUHK Medical Centre Attains ACHSI Accreditation for the First Time

CUHK Medical Centre (CUHKMC) has successfully attained the accreditation from The Australian Council on Healthcare Standards International (ACHSI) on 8 July 2024. The recognition was granted after a comprehensive on-site assessment conducted by the survey team from 17 to 21 June, where all 856 applicable elements were met with no recommendations, in accordance with the 38 criteria in the 7th edition of the Evaluation and Quality Improvement Program (EQuIP7). Dr. Hong FUNG, Chief Executive Officer of CUHK Medical Centre, said, “For CUHKMC that has operated for only 33 months since official opening, this result is undoubtedly encouraging for all of us. The accreditation is a testimony to the concerted effort and dedication of the entire team. CUHKMC will continue to perfect its services and to provide patients with quality and safe medical care.”

11 Mar 2024

Bowtie partners with CUHK Medical Centre to launch the "Medical Insurance + Wellness" Package

Bowtie, Hong Kong's first virtual insurer¹ , is thrilled to announce the partnership with CUHK Medical Centre (CUHKMC), introducing the latest "CUHKMC Wellness Package". This is Bowtie's second VHIS rider plan²; Bowtie aims to continue its previous collaboration with another hospital, proactively promoting a one-stop "Medical Insurance + Wellness" solution for customers residing in different regions, enabling them to enjoy high-end private medical services at an affordable price. Full Reimbursement for 360+ Medical Packages with Transparent Prices Bowtie, CUHKMC, and other private hospitals engaged in the "Pilot Programme for Enhancing Price Transparency for Private Hospitals", shared an aligned rationale of enhancing transparency in pricing by promoting fixed-priced medical packages, enabling customers to clearly acknowledge their medical expenses and manage their medical budget accordingly. For Bowtie’s VHIS-Flexi Plan customers who have selected the "CUHKMC Wellness Package", Bowtie will provide full reimbursement for a wide range of package fees, including 139 day procedures and 228 inpatient operation/ procedures packages. It covers all doctors’ fees and all hospital charges for procedure-related standard items and drugs, which also cover expenses over complications and intensive care arising from the operation/procedure, ensuring they are spared from unexpected financial burdens and could focus solely on their treatment. One-stop "Medical Insurance + Wellness" Solution for "Cashless Hospitalisation" Experience In addition to helping patients have a clearer understanding of their medical budgets, through forging closer collaboration with CUHKMC, Bowtie endeavors to streamline the medical record retrieval process for insurance companies by facilitating the adoption of pre-approval application services, in order to significantly shorten or even waive patients’ long waiting for the reimbursement, which could often amount to substantial sums.  Currently, Bowtie offers its VHIS customers the convenience of downloading the pre-approval form online, and having it filled out by their attending doctors. Once the case is approved, customers will be eligible for the "Cashless Hospitalisation" service. While for the customers who have selected "CUHKMC Wellness Package", they will be issued a specific medical card; by presenting this card for identification purposes, CUHKMC will automatically initiate a pre-approval application to Bowtie on behalf of the patient, eliminating their need to undertake any administrative procedures throughout the entire process. Yearly Personalised Free Check-ups with Targeted Examinations Recommended by Doctors In alignment with the "Early Detection & Timely Intervention" principle outlined in the "Primary Healthcare Blueprint" and considering the increasing prevalence of chronic illnesses among the population, Bowtie and CUHKMC offer comprehensive and tailored physical examination for customers who have selected the "CUHKMC Wellness Package". Unlike the conventional physical examination packages, the customers will be able to enjoy a thorough health consultation session and annual body check at free of charge, as well as BowtiePoints equivalent to HKD 1,500 to manage their personal health effectively. After consultation with a doctor for their professional advice, the customers will be able to conduct an all-rounded body check; after that, they can also use BowtiePoints to choose from over 20 targeted examination items or health services based on their specific needs. Fred NGAN, Co-Founder and Co-CEO of Bowtie, stated, "We have received a very positive response to the first rider product, nearly 20% of Bowtie’s VHIS-Flexi Plan policyholders have chosen to select it. We are confident that introducing similar offerings in partnership with CUHK Medical Centre will enable us to innovate on top of the solid foundation built by VHIS, better cater to medical and wellness needs of citizens residing in the New Territories through transparent prices." Dr. Hong FUNG, Chief Executive Officer of CUHK Medical Centre, said, "We are delighted to collaborate with Bowtie in providing convenient and quality healthcare services to the public. Package fee is transparent and predictable to both patient and insurance company. This collaboration demonstrates the beauty of package fee, leading to a win-win situation for all three parties. On the other hand, the annual free check-up offered by Bowtie can encourage the public to develop the habit of attending health checks on a regular basis, echoing one of the goals of primary healthcare - early detection and early treatment." The "CUHKMC Wellness Package'' is now available for Bowtie’s VHIS Flexi Plan customers, with a monthly premium of HK$200 regardless of age and gender³. To learn more about the details, please visit: https://www.bowtie.com.hk/en/insurance/vhis/hospital-rider/cuhkmc.   ¹ Bowtie is the first company authorized by Hong Kong’s Insurance Authority under its Fast Track Pilot Scheme ² "CUHKMC Wellness Package" is not a certified plan under VHIS ³ "CUHKMC Wellness Package" must be paired with the Bowtie’s VHIS-Flexi Plan and cannot be purchased independently

06 Feb 2024

Opening Ceremony of CUHKMC Neurocognitive Centre; Establishment of Neurocognitive Registry Drives Momentum in Medical Research

CUHK Medical Centre (CUHKMC) established a Neurocognitive Centre with the generous donation from Mr. and Mrs. Maximilian MA to provide early detection and treatment to people affected by related diseases. A Neurocognitive Registry is set up to propel medical research in this aspect. The Neurocognitive Centre is a major part of CUHKMC Clinical Neuroscience Centre (CNC), where CNC is established to provide multi-disciplinary and one-stop neurology and neurosurgery care by consolidating outpatient and inpatient service at CUHKMC, in view of increasing medical needs on dementia, stroke or neurological impairment. Two major service scopes of the CNC include early detection of dementia and rehabilitation on neurodegenerative diseases (e.g. Parkinson’s disease and stroke).  Regarding detection of dementia, the CNC has deployed cutting-edge technology, in particular the high-sensitivity Single Molecule Array digital equipment. It identifies specific biomarkers from blood sample and allows early detection of dementia patients. Furthermore, the CNC can leverage AI-powered AccuBrain to better analyse MRI images and identify dementia patients at an early stage. While on rehabilitation, Transcranial Magnetic Stimulation (TMS), Robotics, Exoskeleton and Virtual Reality (VR) technologies are used to facilitate patients’ rehabilitative exercise and training. The Division of Neurology at the Department of Medicine & Therapeutics of CUHK Faculty of Medicine, together with The Charles K. Kao Foundation for Alzheimer’s Disease, previously launched a free Alzheimer’s disease (AD) screening and assessment service, “Charles Kao CUHK BEAT AD Service” (The BEAT AD), for Hong Kong residents. In light of this, the CNC at CUHKMC joins forces with them to establish a “Neurocognitive Registry”. The initiative is poised to advance medical research on dementia and AD. The BEAT AD involves the use of AI-assisted retinal imaging screening for early AD and provision of tailor-made advice on prevention of AD. Follow-up cases screened by the BEAT AD project will be referred to CUHKMC for further subsidised diagnosis and treatment. CUHKMC aims to identify AD patients at an early stage through advanced neuro-diagnosis and multi-disciplinary intervention programme. Dr. Hong FUNG, Chief Executive Officer of CUHKMC, said, “CUHKMC has earlier established the Clinical Neuroscience Centre (CNC). We are grateful for Mr. and Mrs. Maximilian MA’s generous support, which has made it possible for us to establish the Neurocognitive Centre inside the CNC to treat patients with advanced facilities and equipment. Early prevention, detection and intervention can delay the onset of cognitive problems, especially dementia. Thus, we have joined hands with CUHK and The Charles K. Kao Foundation for Alzheimer’s Disease to establish the ‘Neurocognitive Registry’ to collect clinical data for research purposes, in the hope of achieving breakthroughs in neurocognitive disorder treatment.”

18 Dec 2023

CUHK Medical Centre Hosts “Innovation Symposium - Pioneering Solutions in Healthcare 2023” To Promote New Medical Experience

The “CUHK Medical Centre (CUHKMC) Innovation Symposium - Pioneering Solutions in Healthcare 2023” came to a successful close on 17 December 2023, featuring a series of inspirational and thought-provoking panel sessions and talks by heavyweight speakers and professionals on novel technology in medicine and healthcare. As the second event after its debut in 2021, this year’s event had attracted more than 580 industry leaders and members of the public attending in person and online. In his opening remarks, Dr. Chien LEE, Chairman of the Board of CUHKMC, said, “In the past, people have witnessed the advancements of vaccines and medications, but the past decades have seen more technological advances, revolutionising the healthcare sector. Advances such as artificial intelligence and robotic surgery are transforming healthcare globally, enhancing efficiency of healthcare systems, and boosting clinical practice precision.” The symposium consisted of two sessions. In the morning session themed “Visioning Futures”, targeting at industry and medical professionals, featured four panel sessions delivered by eminent medical professionals and technology experts.  Professor Philip CHIU, Associate Dean (External Affairs) of the Faculty of Medicine and Professor of the Department of Surgery at The Chinese University of Hong Kong (CUHK) gave a keynote address on the future of robotic surgery.  Professor Joseph SUNG, Distinguished University Professor, Senior Vice President (Health & Life Sciences) and Dean, Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, was present to deliver an address on AI in medicine.  Professor Teodor GRANTCHAROV, Professor of Surgery (General Surgery) of the School of Medicine of Stanford University, United States, shared with the audience on how to ensure patient safety in operating room. Ms Fan YANG, Overseas Healthcare Market & Cooperation Representative of the Global Public Sector of Huawei, talked about the future of Internet of Things (IoT) and Internet of Medical Things (IoMT). In the afternoon session themed “Current Advances @ CUHKMC”, CUHK professors and CUHKMC specialists hosted 12 health talks covering a vast range of topics related to minimally invasive surgery, medical innovation and advancement in cancer treatment, to share with public the latest development of medical treatments. (Please refer to the Appendix (in Chinese only) for detailed rundown).  Dr. Hong FUNG, Chief Executive Officer of CUHKMC, said, “Innovation and technology has been playing a significant role in healthcare, and which emphasizes collaboration between working teams, and with counterparts and partners as well. The exchange of knowledge is crucial for advancing innovation and technology. That’s why we have organised this Symposium, to bring together thought leaders, technology experts and innovators to discuss and explore the endless possibilities and implications of innovation technology in healthcare.” The hospital’s first Open House was also organised on the same day, showcasing some of the major services and technologies to members of the public, including Radiotherapy Centre, Imaging & Interventional Radiology Centre, Cardiology Centre, Urology Centre, Eye Centre and Day Surgery Centre.  Appendix (In Chinese only) 醫學新猷健康講座內容 微創手術治療 如何透過白內障手術矯正近視、遠視、散光和老花眼 譚智勇教授 內鏡機械人對早期腸胃癌的治療：從實驗室到臨床 趙偉仁教授 治療良性前列腺增生及前列腺癌的最新微創手術 趙家鋒教授 機械人輔助腹腔鏡前列腺切除術 侯仕明醫生 醫學創新 運動醫學新紀元：創新科技與醫體融合 容樹恒教授 冠狀動脈鈣化血管處理的新技術 陳裕豪醫生 介入性取栓治療 - 中風病人新希望 蔡紹俊醫生 以人工智能擊退腦退化 莫仲棠教授 癌症治療 癌症治療新方向：精和準 陳林教授 肺癌治療的多模式攻略新時代 司徒達麟醫生 微創肝切除術在肝癌治療的最新發展 吳國際醫生 精準腫瘤治療：核磁影像導向放射治療臨床經驗分享 唐美思醫生

12 Dec 2023

中大醫院和互康集團攜手推出醫院賬單理賠分拆服務 提升醫療費用透明度 香港永明金融有限公司高度支持 (Only available in Chinese)

Only available in Chinese

11 Dec 2023

Manulife Hong Kong and CUHK Medical Centre Expand Partnership To Offer Cashless Pre-Approval Service for CUHK Medical Centre’s Over 300 All-Inclusive Hospital Packages

Manulife Hong Kong and CUHK Medical Centre announced today the expansion of their partnership to offer a cashless pre-approval service for over 300 all-inclusive hospital packages, including endoscopic and surgical procedures, provided by CUHK Medical Centre. Upon obtaining pre-approval, Manulife customers with selected medical plans can now access these hospital packages without paying upfront, thereby ensuring increased peace of mind and flexibility. The expanded partnership between Manulife Hong Kong and CUHK Medical Centre underscores their shared commitment to meeting the community’s growing health and protection needs. This collaboration is in line with Manulife’s strategic vision of expanding its medical provider network in Hong Kong and other cities within the Greater Bay Area (GBA), as well as in other parts of Mainland China. It also aligns with CUHK Medical Centre’s mission of delivering quality healthcare services at predictable package fees. “We are proud of our extended partnership with CUHK Medical Centre, which has enabled us to give our customers with selected medical plans easy access to a diverse range of all-inclusive hospital packages covering day and inpatient medical services, all at predictable prices,” said Carrie TONG, Chief Operations Officer at Manulife Hong Kong and Macau. “CUHK Medical Centre’s commitment to quality patient-centred services and clinical excellence perfectly aligns with our own dedication towards providing an exceptional customer journey.” The all-inclusive packages provide Manulife customers with budget certainty while offering well-rounded medical coverage and professional medical services. These packages include hospital room and board, surgeon’s fees, doctor’s visits, medical appliances and more – all under the established clinical governance of CUHK Medical Centre. Dr. Hong FUNG, Chief Executive Officer of CUHK Medical Centre, said: “We are delighted to extend our partnership with Manulife, which we believe will bring about a synergy in delivering quality patient care to those in need. By integrating our package fees with Manulife’s cashless pre-approval arrangement, we aim to provide a seamless and hassle-free patient journey, making it a truly one-stop experience. This echoes well with our patient-first rationale and our mission of providing healthcare services at predictable fees to the community.” In-person and onsite support for a seamless medical experience As part of the expanded partnership, customers with designated plans can benefit from the dedicated support of Manulife's Personalized Medical Case Managers (PMCM). The PMCM team, which includes registered nurses and professionals with healthcare backgrounds, will be assigned to assist customers throughout their treatment journey and ease any health worries they may have. Moving forward, the PMCM service will be expanded to cover other complex surgeries. In addition, onsite ambassadors will be available at CUHK Medical Centre to provide Manulife customers with on-the-spot support for cashless pre-approval, hospital services, and language assistance. This ensures that customers have a superior experience and feel reassured during their visit to CUHK Medical Centre. This latest collaboration builds on Manulife’s earlier partnership with CUHK Medical Centre in 2021, which provided Manulife customers with priority access to CUHK Medical Centre’s oncologists for a one-time, free independent medical consultation. 

07 Dec 2023

CUHK Medical Centre and The GBA Healthcare Group announce strategic cooperation to jointly build The GBA Integrated Value Based Care Partnership Ecosystem

Today, CUHK Medical Centre ("CUHKMC") and The GBA Healthcare Group (HK) Limited ("GBAH Group") signed a strategic cooperation agreement, to jointly build The GBA Integrated Value Based Care Partnership Ecosystem. Dr Hong FUNG, Chief Executive Officer of CUHK Medical Centre and Dr Felix LEE, Co-Chief Executive Officer of the GBA Healthcare Group were present at the signing ceremony for this collaborative. Based on years of experience in Guangdong-Hong Kong medical collaboration, GBAH Group officially launches the initiative to establish "The GBA Integrated Value Based Care Partnership Ecosystem" and announces CUHK Medical Centre as its first partner hospital in Hong Kong. Both parties are committed to patient health outcomes and will jointly provide cross-border healthcare services covering general outpatient services in the Greater Bay Area, and specialized inpatient services in Hong Kong for residents in the Greater Bay Area. Concurrently, CUHKMC declares GBAH Group as its "Designated Value Based Care Insurance Proposition Partner", aiming to meet policyholders' healthcare service needs in Hong Kong by partnering with insurance companies to create health insurance plans that offer all-inclusive package fees and cover cross-border medical services. With the acceleration of the aging society, medical expenses are rapidly increasing. However, there is still a need to improve medical efficiency and effectiveness. Due to insufficient prevention, the number of patients with tumors and chronic diseases is increasing year by year. The disease-centered medical model needs to quickly transition to a health-centered model. “Value-based care” concept emerged in 2006 and has since become a widely discussed topic globally. However, in China, it is still in its early stages. In contrast to traditional healthcare models, value-based care seeks to balance the business paradox of "good, fast, and cheap" by providing better healthcare services and achieving improved health outcomes at more affordable medical costs.  Value-based care has the following characteristics: Focuses on health rather than disease. Charges based on patient health outcomes rather than services. Provides the most cost-effective healthcare services under the premise of improving patient health outcomes. For various stakeholders in healthcare services, value-based healthcare holds the following values: Payers: Controls costs and reduces risks by creating health insurance products based on disease prevention. Providers: Focuses on delivering services most beneficial to patient health without worrying about over or under servicing. Patients: Obtains better treatment and preventive care at a lower cost. By coordinating the incentive mechanisms for payers, healthcare providers, and patients, the goal is to improve societal health levels and reduce overall healthcare expenditures. Dr Hong FUNG, Chief Executive Officer of CUHK Medical Centre (“CUHKMC”), said, "We are delighted to form strategic partnership with GBAH Group, which has been deeply rooted in the Greater Bay Area for many years, promoting Hong Kong-style medical services to multiple cities in the Greater Bay Area through a public-private partnership model. It is a pioneer and promoter of Guangdong-Hong Kong medical collaboration, possessing valuable experience in value-based care practices. CUHKMC shares a common goal with GBAH Group to promote population health, and aim to serve the 87 million residents in the Greater Bay Area through mutual medical support and exchanges, in particular serving the 600,000 Hong Kong residents living in the Greater Bay Area." Dr Felix LEE, Co-Chief Executive Officer of the GBA Healthcare Group (“GBAH Group”), said, "We are delighted that CUHKMC has become the first partner hospital in Hong Kong for The GBA Integrated Value Based Care Partnership Ecosystem. As the convener of the collaborative system, we carefully select clinics, hospitals, insurance companies, technology companies, and other medical-related institutions in the Greater Bay Area. Leveraging the advantages of general prevention and specialized treatment, we harness the dual protection of medical services and health insurance, providing trustworthy, affordable, and easily accessible medical services for residents in the Greater Bay Area. CUHKMC is a private university-affiliated teaching hospital in Hong Kong, with outstanding specialized capabilities and strong research and clinical strength. As the first Hong Kong partner hospital, CUHKMC will complement the mainland medical system, jointly ensuring the health of residents in the Greater Bay Area. So far, GBAH Group has over a hundred partner clinics and 8 partner hospitals being engaged in Guangdong-Hong Kong collaboration, offering diverse choices for healthcare and cross-border medical services for residents in the Greater Bay Area. Going forward, we look forward to collaborating with more partners dedicated to value-based care to jointly create a distinctive value-based care model in the Greater Bay Area." The strategic cooperation between CUHKMC and GBAH Group will begin with research and clinical exchanges at the hospital where the Hong Kong-Macau Residents Healthcare Services Center is located. Through a cross-border two-way referral service model, it aims to enrich healthcare choices for residents in the Greater Bay Area and enhance their medical experience from outpatient to inpatient, from routine care to disease treatment. With the support of the partnership system, the two parties will create innovative insurance products centered around patient health, using the most cost-effective healthcare service payment model to provide residents with the most valuable health coverage. About The GBA Integrated Value Based Care Partnership Ecosystem The GBA Integrated Value Based Care Partnership Ecosystem is a regional collaborative medical service system initiated by GBAH Group. Participants in the partnership system include payers (insurance and reinsurance companies), service providers (hospitals and clinics), technology companies (cross-border data and clinical systems), and retail pharmacies in Hong Kong and cities in the Greater Bay Area. The partnership ecosystem, centered around residents' health, aims to achieve the goal of keeping residents healthy and preventing illnesses through medical collaboration. When residents require medical services, the partnership ecosystem will synergize by integrating internet hospitals, comprehensive primary care services, and hospital specialty diagnostic and treatment resources, leveraging the advantages of cross-border medical services. This ensures that patients receive the most cost-effective treatment and preventive care, enables medical service providers to focus on delivering services that are most conducive to patient health, and allows payers to focus on creating health insurance products favorable for disease prevention, ultimately realizing the goal of trustworthy, affordable, and easily accessible healthcare services. GBAH Group is dedicated to promoting the development of value-based healthcare. Over the past five years, the company has collaborated with various local governments in the Greater Bay Area, establishing a collaborative medical network between Guangdong and Hong Kong, laying the foundation for the implementation of value-based care. Specific measures include: Providing international internet hospital services for convenient customer consultations and health inquiries. The company assigns exclusive family doctors to customers, establishes personalized health records, and achieves long-term continuous health management. Establishing Hong Kong-style general outpatient clinics in the six major cities of the Greater Bay Area for convenient local consultations. These clinics, staffed by family doctors, offer comprehensive, continuous, and personalized care services to families in the Greater Bay Area, providing health care and disease prevention services. Establishing a specialized referral service system in public community health service centers and large public hospitals, organizing Guangdong-Hong Kong expert consultations and multidisciplinary consultations, and coordinating the necessary medical resources. Forming a cross-border service network with Hong Kong outpatient clinics and hospitals to provide customers with cross-border medical services ranging from general to specialized care. Establishing the GBA Integrated Value Based Care Partnership Ecosystem, collaborating with international medical and insurance partners to introduce comprehensive outpatient and inpatient insurance services. This aims to achieve the goals of improving medical outcomes, reducing medical costs, and enhancing patient experience in value-based care.